<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00830622</url>
  </required_header>
  <id_info>
    <org_study_id>H2007:037</org_study_id>
    <secondary_id>CDC PEPFAR PHE KE.07.0045</secondary_id>
    <nct_id>NCT00830622</nct_id>
  </id_info>
  <brief_title>Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya</brief_title>
  <official_title>A Targeted Cell Phone Intervention to Improve Patient Access to Care and Drug Adherence in Patients Taking Antiretroviral (ARV) Medications in Kenya</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Nairobi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical study to evaluate the use of cell phones to support drug adherence and follow-up
      of patients taking antiretroviral therapy (ART) for treatment of HIV. The intervention
      involves health-care providers sending regular short-message-service (SMS) text messages to
      patients and following up their responses. The hypothesis is that the cell phone intervention
      will improve ART adherence and health outcomes compared with the current standard of care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This RCT study focuses on enrolling and following patients initiating ART. Note, a second
      parallel prospective cohort study enrolls and follows ART experienced patients who have
      already been taking ART for at least one year before and after the same intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to ART and HIV RNA suppression</measure>
    <time_frame>6,12 months</time_frame>
    <description>Although many patients are seen every 3 months, study visits with questionnaires and viral load are completed at 0, 6, and 12 month scheduled follow-up visits.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retention</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (SF-12)</measure>
    <time_frame>3, 6, 9, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health (CD4, weight, progression to AIDS, all cause mortality)</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">536</enrollment>
  <condition>HIV</condition>
  <condition>AIDS</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cell Phone Intervention: participant receives weekly SMS text message from the health care worker.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>SOC: Participant receives standard of care support but not weekly SMS text messages from the health care worker.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cell Phone Intervention</intervention_name>
    <description>Participant receives weekly SMS text messages from the health care provider.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV infected and starting antiretroviral therapy

          -  Adequate (daily) access to a cell phone

          -  Intending to attend the enrollment clinic for 2 years

          -  Consent to participate

        Exclusion Criteria:

          -  Not meeting inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard T Lester, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joshua Kimani, MBChB</last_name>
    <role>Study Chair</role>
    <affiliation>University of Manitoba / University of Nairobi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis A Plummer, MD, FRCPC</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nairobi Clinics</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <link>
    <url>http://www.mrsi.ca/</url>
    <description>Manitoba Resistance and Susceptibility to Infection Group</description>
  </link>
  <reference>
    <citation>Lester R, Karanja S. Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management. Lancet Infect Dis. 2008 Dec;8(12):738-9. doi: 10.1016/S1473-3099(08)70265-2.</citation>
    <PMID>19022188</PMID>
  </reference>
  <reference>
    <citation>Lester RT, Gelmon L, Plummer FA. Cell phones: tightening the communication gap in resource-limited antiretroviral programmes? AIDS. 2006 Nov 14;20(17):2242-4.</citation>
    <PMID>17086071</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2009</study_first_submitted>
  <study_first_submitted_qc>January 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2009</study_first_posted>
  <last_update_submitted>June 18, 2010</last_update_submitted>
  <last_update_submitted_qc>June 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Richard T. Lester, MD, FRCPC / Principal Investigator</name_title>
    <organization>Dept. of Medical Microbiology and Infectious Diseases, University of Manitoba</organization>
  </responsible_party>
  <keyword>HIV/AIDS</keyword>
  <keyword>Adherence</keyword>
  <keyword>Antiretroviral Therapy, ART, ARV</keyword>
  <keyword>Mobile phone, cell phone, telephone</keyword>
  <keyword>Text message, SMS</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Africa</keyword>
  <keyword>Resource-limited setting</keyword>
  <keyword>Counseling, support</keyword>
  <keyword>treatment experienced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

